Please login or register first to view this content.
OB/GYN Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Phexxi, a Vaginal pH Regulator, Now Available for Pregnancy Prevention
NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Released
COVID-19 During Pregnancy May Pose Risks for Mother, Baby
Mirena Approved for Pregnancy Prevention for Up to 6 Years
FDA to Review Relugolix Combination Therapy for Uterine Fibroids
Study Findings Support Use of Secnidazole for Trichomoniasis
Medication Use Linked to Weight Gain in Postmenopausal Women
Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
Higher Rates of Pain, Bleeding Found With Essure Birth Control Device
Sustained Clinical Benefits Observed With Linzagolix in Uterine Fibroid Trials
Clinically Meaningful Pain Reduction Observed With Relugolix in Endometriosis Trial
Contraceptives Beneficial for Premature Ovarian Insufficiency
Oral Contraceptive With Novel Estrogen Under FDA Review
Newborn Respiratory Distress Up With Maternal Antidepressant Use
Benzodiazepine Use Linked to Risk for Ectopic Pregnancy
Oriahnn Approved for Heavy Menstrual Bleeding Due to Uterine Fibroids
Rebif Labeling Updated with Pregnancy, Lactation Data
Phexxi, a Vaginal pH Regulator, Approved for Pregnancy Prevention
